Update on Chronic Lung Allograft Dysfunction
2016; Springer Science+Business Media; Volume: 3; Issue: 3 Linguagem: Inglês
10.1007/s40472-016-0112-y
ISSN2196-3029
AutoresJason M. Gauthier, Ramsey R. Hachem, Daniel Kreisel,
Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoChronic lung allograft dysfunction (CLAD) encompasses a range of pathologies that cause a transplanted lung to not achieve or maintain normal function. CLAD manifests as airflow restriction and/or obstruction and is predominantly a result of chronic rejection. Three distinct phenotypes of chronic rejection are now recognized: bronchiolitis obliterans, neutrophilic reversible allograft dysfunction, and restrictive allograft syndrome. Recent investigations have revealed that each phenotype has a unique pathology and histopathological findings, suggesting that treatment regimens should be tailored to the underlying etiology. CLAD is poorly responsive to treatment once diagnosed, and therefore, the prevention of the factors that predispose a patient to develop CLAD is critically important. Small and large animal models have contributed significantly to our understanding of CLAD, and more studies are needed to develop treatment regimens that are effective in humans.
Referência(s)